Email Updates

You are here

Home»Media

AVAC in the News

  • Partners Must Prioritize Access in Fight Against HIV/AIDS, Experts Say

    Over the past 30 years, advances ranging from medical technology to policy implementation have reduced new infections and suppressed the virus for those already living with HIV. There is a lot of excitement about technological innovations already on the market and those that will be available in the near future, including preexposure prophylaxis, or PrEP, which could soon be available as implants instead of daily pills. But progress in the global fight against HIV has been uneven, with the San Francisco Bay Area serving as an example of the global inequities in the disease burden.

    January 9, 2020
    PrEP, Treatment
    Devex

  • Understanding HIV Prevention in High-Risk Adolescent Girls and Young Women in Two South African Provinces

    Creating HIV prevention strategies that resonate with AGYW requires an understanding of the factors influencing their decision-making and behaviour, particularly with respect to relationship management. The study concluded that messages and interventions perceived to jeopardise or increase friction within sexual relationships are unlikely to resonate or effect behaviour change. In order to optimise the impact of HIV prevention messages and programmes, consideration should be given to the priority that AGYW with high-risk behaviours place on relationship preservation and management

    December 31, 2019
    General
    South African Health Review 2019

  • The Decade In Global Health: New Drugs, Faster Trials, Social Media To The Rescue

    There is a problem with the decade's greatest medical moments. Most medical advances originate in rich countries, so they are sometimes out of reach for the world's poor — even when they address health problems more common in low-income countries. Treatment for HIV, for example, became available in the U.S. in 1996 but the rollout in Africa didn't begin until 2002. But some breakthroughs of the past decade have gone on to have a truly global impact.

    December 24, 2019
    Treatment
    NPR

  • Lessons in the Fight Against AIDS

    Inad never planned on being an AIDS advocate. He was set to become a lawyer, enrolling in law school in Mindanao, an island in southern Philippines. But in 2011, in the middle of his studies, he received the news that changed that trajectory. Inad found out he was HIV positive.

    December 16, 2019
    General
    US News & World Report

  • Opinion: We Won’t Meet the 2020 AIDS Targets. Now What?

    As we approach 2020 — a pivotal year on many levels — we have more options and a clearer picture than ever of what must be done to end the HIV epidemic globally.

    December 3, 2019
    Combination Prevention
    Devex

  • The Moon Landing of HIV Vaccine Research: RV144, Ten Years Later

    Buried within a 2009 New England Journal of Medicine article on an HIV vaccine regimen was a sentence that would change the face of HIV vaccine research for the next decade: "the modified intention-to-treat analysis showed a significant, though modest reduction in the rate of HIV-1 infection as compared with placebo."

    December 3, 2019
    HIV Vaccine
    MedPage Today

  • Lessons From HIV/AIDS Response Have Much Wider Resonance

    Much of the progress in fighting HIV/AIDS is thanks to treatments such as antiretroviral (ARV) drugs. Alongside those, however, are other innovations that have provided models for broader moves towards universal health coverage.

    November 28, 2019
    General
    Financial Times

  • Group Advocates Reduction in Age of Access to SRH Services

    The New HIV and Vaccine Microbicides Advocacy Society (NHVMAS) Wednesday urged the Federal Ministry of Health to reduce the age of access for both Sexual Reproductive Health (SRH) and HIV testing services to 14 years. The civil society organisation, which made this known at a round table discussion in Abuja, in collaboration with AVAC and GADO Agency LTD Nigeria, also urged the government to integrate SRH education into the curriculum of schools.

    November 20, 2019
    General
    The Nation

  • Untangling the Trump Administration’s Lawsuit Over an HIV Prevention Drug

    The US government routinely sues pharmaceutical companies for making false claims, bilking Medicare, illegal kickbacks, and sloppy manufacturing practices. But on 6 November, the US Department of Justice (DOJ) filed suit against Gilead Sciences Inc. of Foster City, California, for reasons that cannot easily fit on a bumper sticker.

    November 8, 2019
    PrEP
    Science

  • HHS to Gilead: Pay Up for PrEP Patent Use

    The Trump administration, on behalf of the Department of Health and Human Services (HHS), filed a patent infringement lawsuit against pharmaceutical manufacturer Gilead Sciences, seeking damages from infringement on HHS patents related to HIV prevention medications, the agency announced on Wednesday night.

    November 7, 2019
    PrEP
    MedPage Today

Pages